TY  - JOUR
AU  - Lorenzo González, Laura
AU  - Valdés Delgado, Teresa
AU  - Vázquez Morón, Juan María
AU  - Castro Laria, Luisa
AU  - Leo Carnerero, Eduardo
AU  - Maldonado Pérez, María Belén
AU  - Sánchez Capilla, Damián
AU  - Pallarés Manrique, Héctor
AU  - Sáez Díaz, Antonia
AU  - Argüelles Arias, Federico
AU  - Grupo de Enfermedad Inflamatoria de Andalucía
PY  - 2022
DO  - 10.17235/reed.2020.7352/2020
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/21699
T2  - Revista espanola de enfermedades digestivas
AB  - ustekinumab is a monoclonal antibody that inhibits interleukins IL-12 and IL-23, and is approved for the treatment of Crohn's disease (CD) and, more recently, also ulcerative colitis (UC). The aim of this study was to evaluate the effectiveness and...
LA  - en
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - Crohn Disease
KW  - Female
KW  - Humans
KW  - Male
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Ustekinumab
TI  - Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.
TY  - research article
VL  - 114
ER  -